logo-cropped

Published in Insurance
Published in Insurance

ATLANTA, GA--(Marketwired - Nov 7, 2013) - MissionIR today announces the online availability of its interview with CytRx Corp. (NASDAQ: CYTR) President and Chief Executive Officer Steven Kriegsman, as well as the company's Vice President of Business Development and Investor Relations David Haen. The full audio interview is available at: http://cytr.missionir.com/interview.html.

CytRx is a biopharmaceutical R&D company developing cancer drugs for several indications. The company's primary focus is on its proprietary delivery technology for potent oncology therapies.

Bayoubuzz.com provides this article only as a news aggregator, NOT as the publisher or as the author. After reading this small portion of the article, please click upon the ORIGINAL SOURCE link above and read the original article. Thank you.


Hover over video bottom right and click full screen for better viewing

latter-blum2

Share Bayoubuzz

Powered By JFBConnect